{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:27:13Z","timestamp":1773264433014,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ijantimicag.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T14:34:32Z","timestamp":1392388472000},"page":"319-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Of stewardship, motherhood and apple pie"],"prefix":"10.1016","volume":"43","author":[{"given":"David M.","family":"Livermore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.01.011_bib0005","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/jac\/dks202","article-title":"Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart\u2014Then Focus","volume":"67","author":"Ashiru-Oredope","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0010","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/jac\/dkq367","article-title":"Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals","volume":"65","author":"Cooke","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0015","first-page":"CD003543","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"4","author":"Davey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkp004","article-title":"Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis","volume":"63","author":"Scheetz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0025","series-title":"Results from the mandatory Clostridium difficile reporting scheme","author":"Public Health England","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0030","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/jac\/dkt212","article-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?","volume":"68","author":"Livermore","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2014.01.011_bib0035","first-page":"ii55","article-title":"BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001\u201306","volume":"62","author":"Livermore","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0050","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/AAC.01737-10","article-title":"Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes","volume":"55","author":"Sader","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijantimicag.2009.03.021","article-title":"Activity of cephalosporin CXA-101(FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates","volume":"34","author":"Livermore","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0060","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/AAC.01104-09","article-title":"Activity of a new cephalosporin, CXA-101 (FR264205), against \u03b2-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients","volume":"54","author":"Moya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.00756-10","article-title":"Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae","volume":"55","author":"Livermore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0070","series-title":"Written evidence submitted by AstraZeneca (AMR0018) to House of Common Science and Technology Committee Inquiry on Antimicrobial Resistance","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0075","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1749-6632.2011.06215.x","article-title":"Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future","volume":"1230","author":"Unemo","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2014.01.011_bib0080","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1136\/sextrans-2012-050913","article-title":"Current and future treatment options for gonorrhoea","volume":"89","author":"Ison","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0085","series-title":"GRASP 2008 report: trends in antimicrobial resistant gonorrhoea","article-title":"The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Steering Group","year":"2009"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1473-3099(13)70143-9","article-title":"Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007\u20132011","volume":"13","author":"Ison","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0100","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/jac\/dkt167","article-title":"Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors","volume":"68","author":"Ostholm-Balkhed","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular epidemiology of Escherichia coli producing CTX-M \u03b2-lactamases: the worldwide emergence of clone ST131 O25:H4","volume":"35","author":"Peirano","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijantimicag.2012.05.003","article-title":"Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus","volume":"40","author":"Hammerum","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2014.01.011_bib0120","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/504484","article-title":"Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?","volume":"43","author":"Kollef","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh482","article-title":"Antibiotic cycling or rotation: a systematic review of the evidence of efficacy","volume":"55","author":"Brown","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0130","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.jss.2011.12.014","article-title":"A 9-year retrospective review of antibiotic cycling in a surgical intensive care unit","volume":"176","author":"Sarraf-Yazdi","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0135","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1086\/323761","article-title":"Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control","volume":"33","author":"Bonten","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2014.01.011_bib0140","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0924-8579(10)70005-4","article-title":"Antibiotic heterogeneity","volume":"36","author":"Masterton","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0145","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/jac\/dkl097","article-title":"Impact of diversity of antibiotic use on the development of antimicrobial resistance","volume":"57","author":"Sandiumenge","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00564-13","article-title":"Determination of in vitro activity of solithromycin at different pHs and its intracellular activity tested against clinical isolates of Neisseria gonorrhoeae from a laboratory collection","author":"Mallegol","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0155","series-title":"53rd interscience conference on antimicrobial agents and chemotherapy (ICAAC)","article-title":"Novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae (NG) and Staphylococcus aureus (SA)","author":"Alm","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","article-title":"Trends among pathogens reported as causing bacteraemia in England, 2004\u20132008","volume":"17","author":"Wilson","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2014.01.011_bib0165","first-page":"ii41","article-title":"BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001\u201306","volume":"62","author":"Livermore","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0170","doi-asserted-by":"crossref","first-page":"e62323","DOI":"10.1371\/journal.pone.0062323","article-title":"Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis\u2014a systemic review and meta-analysis","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0175","doi-asserted-by":"crossref","first-page":"e000392","DOI":"10.1136\/bmjopen-2011-000392","article-title":"Accuracy of LightCycler\u00ae SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review protocol","volume":"2","author":"Dark","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0180","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1128\/JCM.01092-13","article-title":"Detection of colonization by carbapenemase-producing Gram-negative bacilli in patients by use of the Xpert MDRO assay","volume":"51","author":"Tenover","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijantimicag.2013.02.026","article-title":"Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay","volume":"42","author":"Magooa","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/JCM.02452-13","article-title":"Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples","volume":"52","author":"Hasman","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/JCM.01630-09","article-title":"Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A\/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection","volume":"48","author":"Kvach","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/sextrans-2011-050075","article-title":"Comparative performance of culture using swabs transported in Amies medium and the Aptima Combo 2 nucleic acid amplification test in detection of Neisseria gonorrhoeae from genital and extra-genital sites: a retrospective study","volume":"88","author":"Harryman","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0205","doi-asserted-by":"crossref","first-page":"e8107","DOI":"10.1136\/bmj.e8107","article-title":"Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study","volume":"345","author":"Stewart","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2014.01.011_bib0210","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc9234","article-title":"Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit","volume":"14","author":"Yanagihara","year":"2010","journal-title":"Crit Care"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T13:24:42Z","timestamp":1538832282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0924857914000259"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Of stewardship, motherhood and apple pie","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}